Yes0%
Vol$0.00
Outcomes2
Event
MarketKALSHIactive
MarketKALSHIactiveOther
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
Part of: When will the FDA approve Intellia Therapeutics' lonvo-z?NoNo Price
100¢
|
VolTotal Volume
$0.00
|
Outcomes
2
Ends
Oct 8, 2027
in about 1 yearWhen will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
No
100¢
|
Vol
$0.00
|
Outcomes
2
Yes0.5¢
No99.5¢
Price History
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
No historical data available
Price history will appear here when available
Resolution Info
Market Stats
Resolution Countdown
455 Days Left
October 08, 2027 • 2:00 PM
Last Updated
less than a minute ago